A dopamine receptor (DRD2) but not dopamine transporter (DAT1) gene polymorphism is associated with neurocognitive development of Mexican preschool children with lead exposure
- PMID: 21592505
- PMCID: PMC3158955
- DOI: 10.1016/j.jpeds.2011.03.043
A dopamine receptor (DRD2) but not dopamine transporter (DAT1) gene polymorphism is associated with neurocognitive development of Mexican preschool children with lead exposure
Abstract
Objective: To investigate the effects of prenatal and postnatal lead exposure and polymorphisms in dopamine metabolism genes on neurocognitive development of Mexican children at 24 months (n = 220) and 48 months (n = 186) of age.
Study design: We genotyped the dopamine transporter gene (DAT1; SLC6A3) variable nucleotide tandem repeat and the dopamine receptor D2 (DRD2) Taq1A single nucleotide polymorphism. Children were assessed at 24 months with Bayley Scales of Infant Development (Mental Development Index and Psychomotor Development Index) and at 48 months with McCarthy Scales of Children's Abilities.
Results: Blood lead concentration (BLL) in umbilical cord was 6.6 ± 3.3 μg/dL (measured in 1995-96), 8.1 ± 4.4 μg/dL at 24 months, and 8.1 ± 3.6 μg/dL at 48 months. Cord BLL was negatively associated with Mental Development Index (P < .01) and Psychomotor Development Index (P < .1), but not McCarthy scores. The 48-month BLL, but not the 24-month BLL, was negatively associated with children's scores. Children with DRD2 TT genotype (variant) scored higher than children with CC genotype (wild type) on the Mental Development Index and McCarthy memory scale. Neither polymorphism modified the relationship between BLL (either prenatal or postnatal) and neurocognitive development.
Conclusion: Lead exposure was adversely associated with neurocognitive measures, whereas the DRD2 Taq1A TT variant was positively associated with neurocognitive measures. We found no evidence of gene-environment interactions on developmental outcomes in early childhood.
Copyright © 2011 Mosby, Inc. All rights reserved.
References
-
- Bellinger D, Leviton A, Allred E, Rabinowitz M. Pre- and postnatal lead exposure and behavior problems in school-aged children. Environ Res. 1994;66(1):12–30. - PubMed
-
- Canfield RL, Kreher DA, Cornwell C, Henderson CR., Jr Low-level lead exposure, executive functioning, and learning in early childhood. Child Neuropsychol. 2003;9:35–53. - PubMed
-
- Froehlich TE, Lanphear BP, Dietrich KN, Cory-Slechta DA, Wang N, Kahn RS. Interactive effects of a DRD4 polymorphism, lead, and sex on executive functions in children. Biol Psychiatry. 2007;62:243–9. - PubMed
-
- Cory-Slechta DA. Relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic, and glutamatergic neurotransmitter system functions. Ann Rev Pharmacol Toxicol. 1995;35:391–15. - PubMed
-
- Jones DC, Miller GW. The effects of environmental neurotoxicants on the dopaminergic system: a possible role in drug addiction. Biochem Pharmacol. 2008;76:569–81. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K01ES14907/ES/NIEHS NIH HHS/United States
- P30ES00002/ES/NIEHS NIH HHS/United States
- P30 ES000002/ES/NIEHS NIH HHS/United States
- R01ES007821/ES/NIEHS NIH HHS/United States
- R01 ES013744/ES/NIEHS NIH HHS/United States
- R01ES013744/ES/NIEHS NIH HHS/United States
- R01 ES014930/ES/NIEHS NIH HHS/United States
- R01ES014930/ES/NIEHS NIH HHS/United States
- K23 ES000381/ES/NIEHS NIH HHS/United States
- P42 ES016454/ES/NIEHS NIH HHS/United States
- K23ES000381/ES/NIEHS NIH HHS/United States
- P42ES016454/ES/NIEHS NIH HHS/United States
- K01 ES014907/ES/NIEHS NIH HHS/United States
- R01 ES007821/ES/NIEHS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical